Alcon AG
Change company Symbol lookup
Select an option...
ALC Alcon AG
BEN Franklin Resources Inc
REGN Regeneron Pharmaceuticals Inc
PSNL Personalis Inc
CORR CorEnergy Infrastructure Trust Inc
SBRA Sabra Health Care REIT Inc
ZI ZoomInfo Technologies Inc
ATNI ATN International Inc
BAC Bank of America Corp
RACE Ferrari NV

Health Care : Health Care Equipment & Supplies | Large Cap Growth
Based in Switzerland
Company profile

Alcon AG is a Switzerland-based company specialized in the medical industry. The Company operates mainly as an eye care device company. Alcon AG reports its activities into two segments: Surgical and Vision Care. The surgical segment provides a line of ophthalmic surgical products that enable surgeons to achieve accurate results. Its surgical portfolio includes technologies and devices for cataract, retinal, refractive surgery, as well as advanced technology intraocular lenses (ATIOLs) to treat cataracts and refractive errors, such as presbyopia and astigmatism. The surgical segment also includes advanced viscoelastics, surgical solutions, surgical packs and other disposable products for cataract and vitreoretinal surgery. The Vision Care segment manufactures contact lenses and lens care products, such as products for dry eye, contact lens care, ocular allergies, as well as ocular vitamins and redness relievers. The Company also offers continuing education for eye care professionals.

Day's Change
0.65 (0.83%)
B/A Size
Day's High
Day's Low

Today's volume of 651,944 shares is on pace to be in-line with ALC's 10-day average volume of 862,145 shares.


Apple stock is a 'place to hide' amid volatile markets, says analyst

1:54 pm ET January 14, 2022 (MarketWatch)

By Emily Bary

The iPhone business looks set up for a strong 2022, according to Piper Sandler

Following a rocky start to the year for technology stocks, Apple Inc. shares may represent a safe haven.

The company (AAPL) could continue to see strong iPhone demand throughout 2022, and while some are worried that demand for PCs and Macs will cool after a pandemic-driven boom, expectations have already been "tempered," according to Piper Sandler analyst Harsh Kumar.

Given the company's prospects for the year ahead and the volatile tech backdrop, he recommended Friday that technology investors "look at Apple as a 'place to hide' in the current environment."

When it comes to Apple's story, "nothing matters like the iPhone," he wrote, adding that this part of the business seems well positioned for 2022. In the U.S., carriers continue to build out their 5G networks and offer subsidies on new phones, which could help drive demand. China represents a further source of strength, and India has the potential play an increasing role in the years to come.

Subscribe: Want intel on all the news moving markets? Sign up for our daily Need to Know newsletter

Looking more broadly at Apple's narrative, Kumar sees opportunity for the company to eventually notch a $4 trillion valuation by becoming a bigger player in the worlds of healthcare and automobiles. (Apple has been knocking on the door of a $3 trillion market value, with shares having reached the required threshold in intraday trading earlier in January but failing to close at that level.)

"In healthcare, we see the Apple Watch continuing to add more and more features, with the goal of eventually offering a blood sugar monitoring system," he wrote. As for the automotive space, Apple reportedly is interested in developing a car. Such a project "makes sense," in Kumar's view, given the car represents a hardware platform on which Apple can sell its services."

Kumar bumped up his price target on Apple shares to $200 from $175, while keeping an overweight rating.

Shares of Apple are off 0.5% in Friday afternoon trading. They've advanced 19% over the past three months, as the Dow Jones Industrial Average has gained just about 2%.

-Emily Bary


(END) Dow Jones Newswires

January 14, 2022 13:54 ET (18:54 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.